Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact

Blood (2017) 129 (20): 2760–2770.

https://doi.org/10.1182/blood-2016-11-747022

Published: 2017

Includes: Supplemental data

Journal Articles

Genetic Alterations In Immune Cell Crosstalk Genes In Diffuse Large B-Cell Lymphoma Predict Survival

Daisuke Ennishi, MD, PhD, Fong Chun Chan, MSc, David W. Scott, MBChB PhD, Christoffer Hother, MD, PhD, Barbara Meissner, PhD, Merrill Boyle, B.Sc., Ryan D Morin, Laurie H. Sehn, MD, MPH, Marco A. Marra, PhD, Joseph M. Connors, MD, Christian Steidl, MD, Randy D. Gascoyne, MD

Blood (2013) 122 (21): 500.

https://doi.org/10.1182/blood.V122.21.500.500

Published: 2013

Journal Articles

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

Fazila Asmar, MD, Christoffer Hother, MD, PhD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD PhD, Helene Myrtue Nielsen, MSc, Ralfkiaer Ulrik, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Elisabeth Ralfkiaer, MD, DMSc, Peter de Nully Brown, MD, Kirsten Grønbæk, MD, DMSc

Blood (2013) 122 (21): 83.

https://doi.org/10.1182/blood.V122.21.83.83

Published: 2013

Journal Articles

miRNA Profiling Predicts Survival and Identifies a Novel Putative Oncomir in Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy

Christoffer Hother, MD, Ditte Reker, Konstantions Dimopoulos, MD, Steen Knudsen, PhD, Thomas Jensen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 1548.

https://doi.org/10.1182/blood.V120.21.1548.1548

Published: 2012

Journal Articles

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

Christoffer Hother, MD, Fazila Asmar, MD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD, Ditte Reker, Ulrik Ralfkiaer, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 296.

https://doi.org/10.1182/blood.V120.21.296.296

Published: 2012

Journal Articles

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Christoffer Hother, MD, Peter Kristian Rasmussen, MD, Tejal Joshi, PhD, Ditte Reker, Ulrik Ralfkiaer, MSc, Christopher Workman, PhD, Peter De Nully Brown, Steffen Heegaard, Prof. MD, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 1600.

https://doi.org/10.1182/blood.V120.21.1600.1600

Published: 2012

Journal Articles

miRNA Profiling in Human Granulopoiesis and in Activated Neutrophils From Skin Window.

Maria Torp Larsen, MD, Christoffer Hother, MD, Mattias Hager, MSc, Corinna Cavan Pedersen, MSc, Lars Jacobsen, MSc, Niels Borregaard, Jack B Cowland

Blood (2012) 120 (21): 2136.

https://doi.org/10.1182/blood.V120.21.2136.2136

Published: 2012

Journal Articles

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML

Marianne Bach Treppendahl, Xiangning Qiu, Alexandra Søgaard, Xiaojing Yang, Cecilie Nandrup-Bus, Christoffer Hother, Mette Klarskov Andersen, Lars Kjeldsen, Lars Möllgaard, Eva Hellström-Lindberg, Johan Jendholm, Bo T. Porse, Peter A. Jones, Gangning Liang, Kirsten Grønbæk

Blood (2012) 119 (1): 206–216.

https://doi.org/10.1182/blood-2011-06-362541

Published: 2012

Includes: Supplemental data

Journal Articles

MicroRNA-130a–mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors

Mattias Häger, Corinna Cavan Pedersen, Maria Torp Larsen, Mette Klarskov Andersen, Christoffer Hother, Kirsten Grønbæk, Hanne Jarmer, Niels Borregaard, Jack Bernard Cowland

Blood (2011) 118 (25): 6649–6659.

https://doi.org/10.1182/blood-2011-03-339978

Published: 2011

Includes: Supplemental data

Journal Articles

Mir-130a-Mediated Downregulation of SMAD4 Contributes to Reduced Sensitivity to TGFβ Stimulation in Promyelocytic Cells,

Mattias Hager, Corinna Cavan Pedersen, Maria Torp Larsen, Mette Klarskov Andersen, MD, Christoffer Hother, MD, Kirsten Grønbæk, MD, DMSc, Hanne Jarmer, Niels Borregaard, Jack B Cowland

Blood (2011) 118 (21): 3383.

https://doi.org/10.1182/blood.V118.21.3383.3383

Published: 2011

Journal Articles

Allelic Methylation Levels of the Non-Coding RNA Gene VTRNA2-1 Located on Chromosome 5q31.1 Predict Outcome in AML,

Marianne B. Treppendahl, MD, Xiangning Qiu, MD, Alexandra Søgaard, MSc, Cecilie Nandrup-Bus, MSc, Christoffer Hother, MD, Mette Klarskov Andersen, MD, Lars Kjeldsen, MD, PhD, Lars Möllgård, MD, Eva Hellstrom-Lindberg, MD, PhD, Johan Jendholm, MSc, Bo T. Porse, PhD, Peter A. Jones, PhD, DSc, Gangning Liang, PhD, Kirsten Grønbæk, MD, DMSc

Blood (2011) 118 (21): 3450.

https://doi.org/10.1182/blood.V118.21.3450.3450

Published: 2011

Journal Articles

TET2 mutations in Diffuse Large B-Cell Lymphoma: The Role of TET2 in the Regulation of Methylation Patterns at TET2 Target Genes

Fazila Asmar, Jesper Christensen, Jens V Johansen, Anders Blåbjerg, Anja Pedersen, Christoffer Hother, Ulrik Ralfkiaer, Kristian Helin, Kirsten Grønbæk

Blood (2011) 118 (21): 1364.

https://doi.org/10.1182/blood.V118.21.1364.1364

Published: 2011

Journal Articles

Epigenetic Silencing of a Novel Candidate Tumor Suppressor “miR” Predicts Poor Prognosis In High-Risk MDS and AML.

Marianne B. Treppendahl, MD, Xiangning Qiu, MD, Christoffer Hother, MD, Mette K. Andersen, MD, PhD, Lars Kjeldsen, MD, PhD, Peter Jones, Professor, Gangning Liang, PhD, Kirsten Gr∅nbæk, MD, PhD

Blood (2010) 116 (21): 3629.

https://doi.org/10.1182/blood.V116.21.3629.3629

Published: 2010

Journal Articles

Onco-Mir-155 Targets SHIP to Regulate TNF-Dependent B-Cell Lymphoma Growth

Irene Munk Pedersen, Dennis C Otero, Elaine Kao, Ana Sedy, Christoffer Hother, Elisabeth Ralfkiaer, Robert C Rickert, Kirsten Gronbaek, Michael David

Blood (2008) 112 (11): 604.

https://doi.org/10.1182/blood.V112.11.604.604

Published: 2008

NARROW

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact

Genetic Alterations In Immune Cell Crosstalk Genes In Diffuse Large B-Cell Lymphoma Predict Survival

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

miRNA Profiling Predicts Survival and Identifies a Novel Putative Oncomir in Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

miRNA Profiling in Human Granulopoiesis and in Activated Neutrophils From Skin Window.

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML

MicroRNA-130a–mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors

Mir-130a-Mediated Downregulation of SMAD4 Contributes to Reduced Sensitivity to TGFβ Stimulation in Promyelocytic Cells,

Allelic Methylation Levels of the Non-Coding RNA Gene VTRNA2-1 Located on Chromosome 5q31.1 Predict Outcome in AML,

TET2 mutations in Diffuse Large B-Cell Lymphoma: The Role of TET2 in the Regulation of Methylation Patterns at TET2 Target Genes

Epigenetic Silencing of a Novel Candidate Tumor Suppressor “miR” Predicts Poor Prognosis In High-Risk MDS and AML.

Onco-Mir-155 Targets SHIP to Regulate TNF-Dependent B-Cell Lymphoma Growth

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only